Share new trends in technology and health
The successful holding of the 2022 annual summary and commendation conference of HEC group
2023-03-31
From March 29 to 31, 2023, HEC group's 2022 annual summary and commendation conference was successfully held at the group headquarters. Zhang Yushuai, group chairman, Zhu Yingwei, rotating chairman of the board of directors of the group, group directors Guo Meilan, Tang Xinfa, Lu Yuxin, Zhang Hongwei, Deng Xinhua, Zhang Liang, group supervisors Hu Zhidong, Zhou Lin, Wei Cailiang, as well as advanced representatives and backbone representatives from various fronts such as R&D, production, sales, and functions participated in this conference.
The theme of this conference is "unify strategy, unite and strive, create and share together, and strive to write a new chapter of high-quality development". This conference is divided into three main parts: March 29, the expanded member meeting of the board of directors of the group; March 30-31, plenary formal meeting; March 31, 2020-2022 annual commendation and award ceremony in the afternoon.
一、Expanded member meeting of the groupboard of directors
On March 29th, at the expanded member meeting of the group, participants from the three major industries of the group made speeches on the new electronic materials industry, the pharmaceutical industry, and the health industry in turn. In the R&D section, the R&D projects were comprehensively sorted out, and the project R&D nodes and industrialization time were clarified; production and sales made speeches on the completion of the 2023 annual target tasks and the implementation of the five-year strategic plan. The functional system department made a speech on the completion of the 2023 target tasks and the provision of higher-quality development empowerment support for industrial development and company management. All directors gave concluding speeches according to the division of management. Finally, the chairman affirmed the achievements made in 2022 and put forward requirements for the development in 2023.
(Picture 1: Group photo of the expanded member meeting of the board of directors of the group)
(Picture 2: Chairman Zhang Yushuai delivered a speech)
(Picture 3: Scene 1 of the expanded member meeting of the board of directors of the group)
(Picture 4: Scene 2 of the expanded member meeting of the board of directors of the group)
二、Formal plenary meeting
From March 30th to 31st, a plenary formal meeting was held. At the meeting, the heads of R&D, production, and sales sectors made a summary of 2022 and planning for 2023. Zhou Lin, supervisor of the group and assistant of the chairman, made a speech on the summary and planning of capital operation; Hu Zhidong, supervisor and chief accountant of the group, made a speech on the summary and planning of the equity incentive work; Deng Xinhua, director of the group, dean of the General Research Institute, head of the financial system, made a speech on the summary and planning of the financial system; Zhu Yingwei, rotating chairman of the board of directors of the group and general coordinator of the biomedical industry, made a speech on the summary and strategic planning of the pharmaceutical industry; Zhang Hongwei, director of the group and general coordinator of the new electronic materials industry, made a speech on the summary and strategic planning of the new electronic materials industry; Lu Yuxin, director of the group and general coordinator of the health industry, made a speech on the summary and strategic planning of the health industry; Tang Xinfa, director and general manager of the group, made a speech on the overall operation of the group in 2022 and announced the optimization and adjustment of the group's organizational construction.
(Picture 5: Scene photo of the plenary formal meeting)
(Picture 6: Zhou Lin, the supervisor of the group and assistant of the chairman, made a speech)
(Picture 7: Hu Zhidong, the supervisor and chief accountant of the group)
(Picture 8: Deng Xinhua, director of the group, dean of the General Research Institute, and head of the financial system)
(Picture 9: Zhu Yingwei, rotating chairman of the board of directors of the group and general coordinator of the biomedical industry)
(Picture 10: Zhang Hongwei, director of the group and general coordinator of the new electronic materials industry)
(Picture 11: Lu Yuxin, director of the group and general coordinator of health industry)
(Picture 12: Tang Xinfa, director and general manager of the group)
At the meeting, Zhang Yushuai, chairman of the group, delivered an important speech on the theme of " unify strategy, unite and strive, create and share together, and strive to write a new chapter of high-quality development".
(Picture 13: Zhang Yushuai, chairman of the group, delivered a speech)
The chairman made a speech from five aspects. First, to firmly inherit and continue to promote the company's excellent culture; second, to summarize the development and management of the group in 2022; third, what is the basis for us to go through the past three years safely and steadily; fourth, the company's next five-year development strategy plan and 2023 annual tasks; fifth, how to achieve our strategic goals.
Part I Firmly inherit and continue to promote the company's excellent culture
(1) Adhere to the legal management of the general outline
(2) Adhere to the character of "loyalty, rules, planning and innovation" of HEC staff
(3) The company always regards "a most-competent army, a school of personnel training, and a family of harmony and friendliness" as the goal of organizational construction
(4) Adhere to the principle of " adults has a career, elderly has a support and children has a dependence"
(5) Thousands of truths, ten thousand truths, development is the last word
Part II Summary of the group's development and management in 2022
(1) The operating performance of the company's three major industries all hit record highs, and the total sales of the group company in 2022 exceeded 41 billion yuan.
(2) Deepen strategic cooperation, lay out major projects, and continuously consolidate the advantages of the industrial chain. It has reached a comprehensive strategic cooperation with Dongyang Municipal Government and invested in the construction of the largest capacitor factory in Dongyang City in China; it has reached a strategic cooperation with Zunyi Municipal Government and Guangzhou Automobile Group to jointly develop lithium ore resources and jointly create a whole industrial chain of "lithium ore-lithium carbonate-cathode material-battery application".
(3) The financing and capital operation work is progressing in an orderly manner, the capital structure is continuously optimized, the investment and financing system is improved, and direct equity financing in the capital market is increased to ensure the safe operation of the company.
(4) Insist on promoting management reform and optimization
Part III What is the basis for us to go through the past three years safely and steadily
(1) Great conduct and virtue, benefiting the society
(2) Work hard to develop the industry and contribute to the country through industry
(3) Unity and struggle with one heart and one mind
(4) Adhere to change and be full of confidence
(5) Implement share reform and promote equity incentives
Part IV The company's next five-year development strategy plan and 2023 annual tasks
(1) The new electronic materials industry builds an internationally leading new energy material platform company. By 2027, the market value of the new electronic materials industry will exceed 100 billion.
(2) The biopharmaceutical industry adheres to the vision of "making medicines for the common people and making HEC a centurial enterprise", and is committed to becoming a leading large-scale pharmaceutical group in China and a world-class one. By 2027, the sales of the pharmaceutical industry will exceed 35 billion yuan, the profit will exceed 10 billion, and the market value will exceed 100 billion.
(3) The health industry has become the leading enterprise of global health. By 2027, the sales volume will strive to exceed 10 billion.
(4) With the three major industrial clusters of electronic new materials, biomedicine and health as the core, through a series of capital operations, four listed companies will be built.
Guangdong HEC Pharmaceuticals is going all out and is expected to apply for listing by the end of 2023. In 2023, the new electronic materials industry plans to raise funds through the capital market and use the securities market to promote industrial development. When the conditions are ripe, it is planned to gradually spin off and list the four major industrial platforms. Biochemical Pharmaceuticals will submit listing application materials to the GEM in 2024. Cordyceps strives to achieve asset securitization in 2026.
HEC will adhere to reform and new development concepts, build a new development pattern, promote high-quality development, and achieve the strategic development goal of the group's revenue exceeding 100 billion by 2027.
Part V How to achieve our strategic goals
(1) To strengthen strategic awareness, awareness of urgency, awareness of unity, awareness of change
(2) Comprehensively promote the construction of a modern enterprise governance system
(3) Continue to promote the innovation of R&D, and accelerate the industrialization of projects
(4) The cultivation of cadres and talents is a long-term strategic project
(5) Be truthful and do your own thing well
三、2020-2022 Annual Commendation Awards Conference
After the plenary formal meeting on March 31, the group commend the 2020-2022 "model workers, outstanding party members, excellent teams, highest science and technology award, first prize of scientific progress, research and development elites, production elites, sales elites, and management elites" one by one.
(Picture 14: Model workers in 2020)
(Picture 15: Outstanding party members in 2022)
(Picture 16: Outstanding Team in 2022)
(Picture 17: First prize of the highest science and technology award in 2020
(Picture 18: First prize of scientific and technological progress award in 2022)
(Picture 19: Group photo of elite awardees in 2020)
(Picture 20: Group photo of elite awardees in 2021)
(Picture 21: Group photo of elite awardees in 2022)
In the end, all the participants had dinner together, and they raised their glasses together to send the most sincere blessings to the group, and to celebrate the successful conclusion of the 2022 annual summary and commendation of HEC Group.
HEC Group has accumulated a solid industrial foundation, a competitive market-oriented mechanism, and a corporate culture of reform and progress, co-creation and sharing. Facing the market opportunities and challenges in 2023, HEC has made full preparations. All HEC staff will unify strategy, unite and strive, create and share together, and strive to write a new chapter of high-quality development of HEC Group, and contribute to the grand cause of Chinese-style modernization.
HEC Group insists on serving the country with industry, and insists on undertaking the business supported by the state and needed by the people. The three major industries that the company vigorously develops are on the advantageous track supported by national strategic policies. With strong winds and waves and a promising future, let us build HEC with a firmer belief, a more tenacious will, a more high-spirited state, and a more solid style of work. Under the strong and correct leadership of the board of directors of the group, with the strong support of governments at all levels and partners, and with the hard work of all HEC staff, we will be able to achieve the great goals of "common prosperity" and "centurial HEC".
Previous page
Related news
The 2021 Annual Summary and Commendation Conference of HEC Group was successfully held
2022-01-12
WeChat public account
2022 Copyright by HEC Group 粤ICP备19034764号-1
